We are live on ! Find out more
SC

Sessa Capital Portfolio holdings

AUM $5.51B
1-Year Est. Return 47.23%
This Fund
S&P 500
This Quarter Est. Return
-2.46%
1 Year Est. Return
+47.23%
3 Year Est. Return
+78.73%
5 Year Est. Return
+129.49%
10 Year Est. Return
+553.63%
AUM
$2.09B
AUM Growth
+$68.8M
Cap. Flow
+$76.2M
Cap. Flow %
3.64%
Top 10 Hldgs %
72.78%
Holding
59
New
15
Increased
5
Reduced
8
Closed
16

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$223M
2
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$123M
3
WBD icon
Warner Bros
WBD
+$35.9M
4
AIV
Aimco
AIV
+$26.5M
5
FLEX icon
Flex
FLEX
+$16.9M

Top Sells

Rank Stock Value
1
JXN icon
Jackson Financial
JXN
+$161M
2
WFC icon
Wells Fargo
WFC
+$146M
3
DTM icon
DT Midstream
DTM
+$102M
4
CTVA icon
Corteva
CTVA
+$95.2M
5
WW
WW International
WW
+$40.6M

Sector Composition

Rank Sector Weight
1 Materials 19.75%
2 Communication Services 14.82%
3 Financials 8.42%
4 Healthcare 6.95%
5 Real Estate 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
26
DELISTED
Apellis Pharmaceuticals
APLS
$7.57M 0.36%
+149,000
New +$6.58M
CLDX icon
27
Celldex Therapeutics
CLDX
$2.99B
$7.22M 0.35%
+212,000
New +$6.78M
ASND icon
28
Ascendis Pharma A/S
ASND
$16B
$6.87M 0.33%
+58,500
New +$6.78M
PRTA icon
29
Prothena Corp
PRTA
$425M
$6.84M 0.33%
+187,000
New +$6.74M
CRSP icon
30
CRISPR Therapeutics
CRSP
$4.73B
$6.78M 0.32%
+108,000
New +$6.78M
PTGX icon
31
Protagonist Therapeutics
PTGX
$8.79B
$6.09M 0.29%
+257,000
New +$7.24M
ACAD icon
32
Acadia Pharmaceuticals
ACAD
$4.43B
$6.03M 0.29%
+249,000
New +$6.03M
TSVT
33
DELISTED
2seventy bio
TSVT
$5.82M 0.28%
341,302
-700
-0.2% -$11.9K
RCUS icon
34
Arcus Biosciences
RCUS
$3.55B
$5.71M 0.27%
+181,000
New +$6.06M
FPAC
35
DELISTED
Far Peak Acquisition Corporation
FPAC
$5.13M 0.25%
516,536
– –
LKFT
36
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
$5.09M 0.24%
82,000
– –
CND
37
DELISTED
Concord Acquisition Corp.
CND
$4.97M 0.24%
500,000
– –
VELO
38
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
$3.91M 0.19%
400,650
– –
AMPS
39
DELISTED
Altus Power
AMPS
$2.66M 0.13%
357,849
-108,709
-23% -$854K
MGNX icon
40
MacroGenics
MGNX
$235M
$2.16M 0.1%
+244,864
New +$2.7M
RXST icon
41
RxSight
RXST
$249M
$2.03M 0.1%
164,282
– –
BHR
42
Braemar Hotels & Resorts
BHR
$156M
$160K 0.01%
25,951
– –
ALLO icon
43
Allogene Therapeutics
ALLO
$649M
– –
-334,396
Closed -$4.99M
BLUE
44
DELISTED
bluebird bio
BLUE
– –
-45,616
Closed -$9.11M
LOGI icon
45
CALL
Logitech
LOGI
$14.7B
– –
-248,500
Closed -$20.5M
LOGI icon
46
PUT
Logitech
LOGI
$14.7B
– –
-777,300
Closed -$64.1M
SEAT icon
47
Vivid Seats
SEAT
$84.6M
– –
-27,816
Closed -$6.05M
SOND
48
DELISTED
Sonder
SOND
– –
-30,084
Closed -$6M
WFC icon
49
CALL
Wells Fargo
WFC
$261B
– –
-1,383,100
Closed -$66.4M
WFC icon
50
Wells Fargo
WFC
$261B
– –
-3,050,210
Closed -$146M
1
2
3

Similar funds

PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $5.49B AUM 19.47% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DWA
Douglass Winthrop Advisors New York $5.46B AUM 11.49% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return

Sessa Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Sessa Capital held 59 positions worth $2.09B, up 3.4% from $2.02B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Sessa Capital deployed $76.2M of net new capital in Q1 2022, opening 15 new positions and adding to 5 existing holdings. Its largest new stake was Discovery, Inc. Series C Common Stock: 4,519,093 shares worth $113M.

By sector, the portfolio is most concentrated in Materials at 20% of assets, down from 27% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Jackson Financial, an estimated $161M trimmed.

  • Sessa Capital's largest Q1 2022 buy was Discovery, Inc. Series C Common Stock: 4,519,093 shares worth $113M.
  • Sessa Capital added most to AT&T in Q1 2022, an estimated $223M increase.
  • Sessa Capital's biggest Q1 2022 reduction was Jackson Financial, cutting an estimated $161M.
  • Sessa Capital fully exited Wells Fargo in Q1 2022, selling an estimated $146M.
  • Sessa Capital's ten largest holdings make up 73% of its $2.09B portfolio in Q1 2022.
  • Sessa Capital opened 15 new positions and closed 16 in Q1 2022.
  • Sessa Capital's portfolio value rose 3.4% quarter-over-quarter to $2.09B.

Based on Sessa Capital's 13F filing for Q1 2022, filed 16 May 2022.